Emerging Alzheimer's disease treatment paradigms: A late‐stage clinical trial review
Abstract INTRODUCTION Without disease‐modifying interventions, Medicare and Medicaid spending on Alzheimer's disease (AD) management is expected to reach 637 billion USD annually by 2050. The recent advent of promising AD therapies after decades of a near‐total failure rate in clinical trials sugges...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wiley
2024-10-01
|
| Reeks: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1002/trc2.70022 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|